It's moving from about $86 million to about $79 million, a change of $7 million, but this money exists in the fiscal framework. It's just about their cashflow needs.
I think it's just words, and I should probably say this, because it's important for a lot of our science and innovation funding. Many of these organizations—Genome Canada, the Canada Foundation for Innovation, etc.—are not A-base entities inside our departmental reference levels. These are actually contributions that are made at the front end, and then new inlays of funding are put in place over time. The money, if you will, is invested up front, and then it can fluctuate normally during the course of the years of the contribution agreement.
For things such as Genome and CFI and others, infrastructure and capital expenditures and so forth are often involved. It's impossible to predict those to the dollar each year, so inevitably there's going to be some fluctuation. But the money they have is in the fiscal framework. It's not that there has been any kind of cut or reduction to their funding.